Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 71

1.

Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.

Thu DC, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ, Faull RL.

Brain. 2010 Apr;133(Pt 4):1094-110. doi: 10.1093/brain/awq047.

PMID:
20375136
2.

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.

Cummings DM, André VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS.

J Neurosci. 2009 Aug 19;29(33):10371-86. doi: 10.1523/JNEUROSCI.1592-09.2009.

3.

Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.

Allen KL, Waldvogel HJ, Glass M, Faull RL.

J Chem Neuroanat. 2009 Jul;37(4):266-81. doi: 10.1016/j.jchemneu.2009.02.001. Epub 2009 Feb 21.

PMID:
19481011
4.

Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?

Rosas HD, Salat DH, Lee SY, Zaleta AK, Hevelone N, Hersch SM.

Ann N Y Acad Sci. 2008 Dec;1147:196-205. doi: 10.1196/annals.1427.034. Review.

5.

Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.

Spampanato J, Gu X, Yang XW, Mody I.

Neuroscience. 2008 Dec 2;157(3):606-20. doi: 10.1016/j.neuroscience.2008.09.020. Epub 2008 Sep 18.

6.

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM.

Brain. 2008 Apr;131(Pt 4):1057-68. doi: 10.1093/brain/awn025. Epub 2008 Mar 12.

7.

Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder.

Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA.

Bipolar Disord. 2008 Feb;10(1):1-37. doi: 10.1111/j.1399-5618.2008.00435.x. Review.

PMID:
18199239
8.

Anterior cingulate dysfunction in geriatric depression.

Alexopoulos GS, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Murphy CF.

Int J Geriatr Psychiatry. 2008 Apr;23(4):347-55. Review.

PMID:
17979214
9.

Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.

Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, Beal MF, Jones L, Kooperberg C, Olson JM, Jones KR.

J Neurosci. 2007 Oct 24;27(43):11758-68.

10.

Neuronal subtype specification in the cerebral cortex.

Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD.

Nat Rev Neurosci. 2007 Jun;8(6):427-37. Review.

PMID:
17514196
11.

Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease.

Gu X, André VM, Cepeda C, Li SH, Li XJ, Levine MS, Yang XW.

Mol Neurodegener. 2007 Apr 30;2:8.

12.

Role of brain-derived neurotrophic factor in Huntington's disease.

Zuccato C, Cattaneo E.

Prog Neurobiol. 2007 Apr;81(5-6):294-330. Epub 2007 Feb 9. Review.

PMID:
17379385
13.

The corticostriatal pathway in Huntington's disease.

Cepeda C, Wu N, André VM, Cummings DM, Levine MS.

Prog Neurobiol. 2007 Apr;81(5-6):253-71. Epub 2006 Dec 13. Review.

14.

Striosomes and mood dysfunction in Huntington's disease.

Tippett LJ, Waldvogel HJ, Thomas SJ, Hogg VM, van Roon-Mom W, Synek BJ, Graybiel AM, Faull RL.

Brain. 2007 Jan;130(Pt 1):206-21. Epub 2006 Oct 12.

PMID:
17040921
15.

Aggregate distribution in frontal and motor cortex in Huntington's disease brain.

van Roon-Mom WM, Hogg VM, Tippett LJ, Faull RL.

Neuroreport. 2006 Apr 24;17(6):667-70.

PMID:
16603932
16.

Regional and cellular gene expression changes in human Huntington's disease brain.

Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RL, Olson JM, Jones L, Luthi-Carter R.

Hum Mol Genet. 2006 Mar 15;15(6):965-77. Epub 2006 Feb 8.

PMID:
16467349
17.

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

André VM, Cepeda C, Venegas A, Gomez Y, Levine MS.

J Neurophysiol. 2006 Apr;95(4):2108-19. Epub 2005 Dec 28.

18.

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.

Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B.

Neurology. 2005 Sep 13;65(5):745-7.

PMID:
16157910
19.

Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.

Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I, Heintz N, Yang XW.

Neuron. 2005 May 5;46(3):433-44.

20.

Supplemental Content

Support Center